| Anthem Blue Cross | Implanted Artificial Iris Devices | 2025-10-01 |
| Anthem Blue Cross | Cancer Antigen 125 Testing | 2025-10-01 |
| Anthem Blue Cross | In Vitro Chemosensitivity Assays and In Vitro Chemoresistance Assays | 2025-10-01 |
| Anthem Blue Cross | Esophageal pH Monitoring | 2025-10-01 |
| Anthem Blue Cross | Home Enteral Nutrition | 2025-10-01 |
| Anthem Blue Cross | Molecular Signature Test for Predicting Response to Tumor Necrosis Factor Inhibitor Therapy | 2025-10-01 |
| Anthem Blue Cross | Ambulatory Electroencephalography | 2025-10-01 |
| Anthem Blue Cross | Quantitative Muscle Testing Devices | 2025-10-01 |
| Anthem Blue Cross | Low-Frequency Ultrasound Therapy for Wound Management | 2025-10-01 |
| Anthem Blue Cross | Automated Evacuation of Meibomian Gland | 2025-10-01 |